Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03241173
Title A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyte Corporation
Indications

Advanced Solid Tumor

transitional cell carcinoma

renal cell carcinoma

Therapies

INCAGN01949 + Ipilimumab

INCAGN01949 + Nivolumab

INCAGN01949 + Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Alabama Birmingham (UAB) Birmingham Alabama 90025 United States Details
Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale Arizona 85258 United States Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
Mount Sinai Medical Center of Florida, Inc. Miami Florida 33140 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
John Theurer Cancer Center At Hackensack UMC Hackensack New Jersey 07601 United States Details
Rutgers, The State University New Brunswick New Jersey 08901 United States Details
New York University Clinical Cancer Center New York New York 10016 United States Details
University of Rochester Medical Center Rochester New York 14642 United States Details
Carolina BioOncology Institute Huntersville North Carolina 28078 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Sarah Cannon Research Institute, LLC (SCRI) Nashville Tennessee 37203 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field